Agios Pharmaceuticals target the metabolism of cancer cells for making drugs that essentially try to repair cancer cells
Reporter: Aviva Lev-Ari, PhD, RN
A small biotech behind a groundbreaking approach to tackling cancer just got its first drug approved
- Lydia Ramsey, Aug. 1, 2017, 11:47 AM
See
Cancer Metabolism
http://www.agios.com/research/cancer-metabolism/
Metabolic Immuno-Oncology
http://www.agios.com/research/metabolic-immuno-oncology/
The VOICE of Larry H. Bernstein, MD, FCAP
Cancer cells didn’t need as much oxygen to metabolize sugar as normal cells.
Not correct. Cancer cells metabolize glucose by aerobic glycolysis (4 ATP) with an impaired mitochondrial oxygen utilization (36 ATP).
There is a reverse Warburg effect in which the underlying stromal cell carries out crosstalk with the epithelial cell.
There is also a 3rd dimension. Cells undergo a series of adaptive changes tied to proteostasis. This involves the sulfur amino acid cysteine and disulfide bonds, which is involved with protein oligomerization in the ER, and also signaling in the mitochondria with mDNA and the nucleus.
Leave a Reply